Daltroban
-
Daltroban
structure -
-
CAS No:
79094-20-5
-
Formula:
C16H16ClNO4S
-
Chemical Name:
Daltroban
-
Synonyms:
SKF-96148;4-[2-[(4-CHLOROPHENYLSULFONYL)AMINO]ETHYL]BENZENEACETIC ACID;2-[4-[2-(4-chlorophenyl)sulfonylaminoethyl]phenyl]acetic acid;BM-13505;DALTROBAN;DatelliptiumChloride;4-[2-[(4-Chlorophenylsulfonyl)amino]ethyl]benzeneaceticacid,BM-13505,SKF-96148;4-[2-(4-Chlorobenzene-sulfonamido)ethyl]benzeneacetic acid
- Categories:
-
CAS No:
Description
Daltroban (BM-13505) is a selective and specific thromboxane A2 (TXA2) receptor antagonist. Daltroban increase intracellular calcium in vascular smooth muscle cells. Daltroban shows protective effect in reperfusion injury[1][2].
Characteristics
91.8
3.95980
white
1.378g/cm3
132.5-137.4 °C(lit.)
555.3ºC at 760 mmHg
289.6ºC
1.609
DMSO: 22 mg/mL, soluble
Safety Information
NONH for all modes of transport
3
36/37/38
26-36/37
Xi
P261-P305 + P351 + P338
H315-H319-H335
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)|Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)
4-(2-(4-chlorobenzenesulfonylamino)ethyl)benzeneacetic acid
Daltroban Use and Manufacturing
It is a specific and powerful antagonist of thromboxane A2 receptor, which can inhibit platelet aggregation, affect thrombosis and prevent sudden death. It is used to treat myocardial ischemia, hemorrhagic shock, endotoxic shock, sudden cardiopulmonary death, acute renal failure, atherosclerosis, etc.
Computed Properties
Molecular Weight:353.8
XLogP3:2.9
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:7
Exact Mass:353.0488569
Monoisotopic Mass:353.0488569
Topological Polar Surface Area:91.8
Heavy Atom Count:23
Complexity:475
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
daltroban
105218-03-9
-
Trimethylolpropane trioleate
57675-44-2
-
Dabigatran etexilate mesylate
872728-81-9
-
Deferasirox Formula
201530-41-8
-
Argatroban Formula
74863-84-6
-
Carbazochrome sodium sulfonate Formula
51460-26-5
-
Clopidogrel Structure
113665-84-2
-
Iron(2+) succinate Structure
10030-90-7
-
What is Protamines
9012-00-4
-
What is (±)-Acenocoumarol
152-72-7